Millennium Management’s NeoGenomics NEO Stock Holding History

Millennium Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-250,000	Closed	-$1.93M	–	6309
2025 Q3	$1.93M	Hold	250,000	–	–	﹤0.01%	4089
2025 Q2	$1.83M	Sell	250,000 -25,000	-9%	-$202K	﹤0.01%	3960
2025 Q1	$2.61M	Buy	+275,000	New	+$3.43M	﹤0.01%	3526
2024 Q2	–	Sell	-345,000	Closed	-$5.42M	–	6323
2024 Q1	$5.42M	Buy	345,000 +125,000	+57%	+$1.93M	﹤0.01%	2781
2023 Q4	$3.56M	Buy	220,000 +70,000	+47%	+$1.15M	﹤0.01%	3089
2023 Q3	$1.84M	Buy	+150,000	New	+$2.23M	﹤0.01%	3628
2022 Q3	–	Sell	-219,200	Closed	-$1.79M	–	7353
2022 Q2	$1.79M	Buy	+219,200	New	+$2.09M	﹤0.01%	3824
2021 Q4	–	Sell	-200,000	Closed	-$9.65M	–	7177
2021 Q3	$9.65M	Buy	+200,000	New	+$9.26M	0.01%	2098

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Millennium Management's NEO Position: Q1 2026 in Review

Millennium Management reduced its NeoGenomics (NEO) stake by 57% in Q1 2026, selling an estimated $31.4M and leaving 2,222,757 shares worth $16.5M. The position accounts for 0.01% of the portfolio, ranked #1706.

Millennium Management first reported a position in NEO in Q4 2013 and has held it in 39 quarters since. The position peaked at $63.8M in Q1 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Millennium Management held 2,222,757 shares of NeoGenomics worth $16.5M as of Q1 2026.
Millennium Management sold 2,981,652 NeoGenomics shares in Q1 2026, an estimated $31.4M.
NeoGenomics made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1706 holding.
Millennium Management first reported a position in NeoGenomics in Q4 2013 and has held it in 39 quarters since.
Millennium Management's NeoGenomics position peaked at $63.8M in Q1 2025.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.